The International Diabetes Federation (IDF) is drawing up new guidelines for the treatment ... with the latest updates as far as professional education goes. So the goal is that the colleagues ...
Objective–To investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist exenatide on weight loss and metabolic parameters in obese nondiabetic women. Research Design ...
The preclinical study, published in Cardiovascular Diabetology, found LXA4, which is known for its "calming agent" action in turning off the body's inflammatory response and preventing chronic ...
The preclinical study, published in Cardiovascular Diabetology, found LXA4, which is known for its “calming agent” action in turning off the body’s inflammatory response and preventing chronic ...
New Delhi, Apr 24 (ANI): A recent study has ... reversing its effects could help aid wound healing in patients with diabetes. "We discovered that a specific protein, thrombospondin-2 (TSP2 ...